About LieffCabraser

"One of the nation's premier plaintiffs firms," Lieff Cabraser has 120 lawyers in San Francisco, New York, Nashville, and Munich. We have a widely diversified practice successfully representing plaintiffs in the fields of personal injury and mass torts, securities and financial fraud, employment discrimination and unlawful employment practices, product defect, consumer protection, antitrust, environmental and toxic exposures, False Claims Act, digital privacy and data security, and civil and human rights. Our clients include individuals, classes and groups of people, businesses, and public and private entities.

Class Action Lawsuits Play Critical Role in the Fight to Protect Consumers and Workers from Being Cheated – Slate.com

Powerful and straightforward piece in Slate reveals how Americans have had their consumer and employee rights stripped away from them Since their inception, class action lawsuits have provided consumers with a mechanism to challenge and deter large corporations from breaking the law. Over the last decade, however, hundreds of millions of Americans have seen themselves

2019-12-18T14:45:49+00:00December 18th, 2019|Consumer Fraud, Employment Law|

Abuse Survivors Can Receive Compensation From Fund Set Up By Six California Catholic Dioceses

Survivors need to be aware of fast-approaching January 31, 2020 deadline for all claims Individuals who were sexually abused by priests across six California Catholic dioceses now have the option to file claims to receive money from a new independent compensation program managed outside the church. The Independent Compensation Program (“ICP”), initially announced in May

2019-12-17T16:00:20+00:00December 17th, 2019|Personal Injury, Sexual Abuse|

Plaintiffs Secure $35M Settlement With Momenta Pharma in Lovenox Blood Clot Drug Antitrust Class Action

As reported by Law360 (subscription), the parties in the Lovenox/Enox blood clot drug antitrust lawsuit have announced a $35 million settlement in the class action lawsuit brought on behalf of thousands of buyers of generic Lovenox (enoxaparin) that accused the company and Sandoz Pharmaceuticals of illegally conspiring to prevent other drug companies from competing in the

2019-12-12T12:44:18+00:00December 12th, 2019|Antitrust, Firm News|

Northern California Wildfire Victims Secure PG&E Agreement to Provide $13.5 Billion in Compensation for Fire Victims

Victims Must File Claims Before December 31, 2019 Court Deadline San Francisco, CA, December 6, 2019 — The Official Tort Claimants Committee (“TCC”), representing fire victims and other tort claimants in Pacific Gas & Electric’s (“PG&E”) bankruptcy reorganization, announce an agreement with PG&E to provide $13.5 billion in compensation for the fire victims and other

2019-12-07T07:30:48+00:00December 7th, 2019|Fires & Burn Injuries, Personal Injury|

Elizabeth Cabraser Talks with Law360 About National Opioids Case, Other Litigation, Career

Law360 (subscription) has published an in-depth interview with Lieff Cabraser partner Elizabeth J. Cabraser that includes a focus on the complexities of navigating the nationwide opioid litigation, which has pitted local communities against the prescription drug industry as those harmed seek redress over the destructive opioid addiction crisis.

2022-08-10T18:15:07+00:00December 7th, 2019|Firm News|